Our monthly feature series “Quality Corner” has been renamed “Rural Initiatives” to reflect recent changes to SDAHO’s quality integration department.
SDAHO is pleased to announce a three-part virtual education series on “Becoming Comfortable with Buprenorphine and MOUD” presented by Dr. Craig Uthe. Since the MATE-ACT took effect in June 2023, health care clinicians have been encouraged to incorporate Buprenorphine into clinical practice for persons with Opioid Use Disorders and/or Chronic Pain. In these sessions, Dr. Uthe will explain why and how buprenorphine use as a continuous medication is on the climb in many clinical and hospital settings. He will also explore future uses currently being evaluated in clinical research.
Sessions:
- March 25: The Role of Buprenorphine in the Clinical Setting: MOUD and Chronic Pain – Part 1
- April 29: The Role of Buprenorphine in the Clinical Setting: MOUD and Chronic Pain – Part 2
- May 27: The Role of Buprenorphine in the Clinical Setting: Latest research on buprenorphine use in other medical conditions
These sessions are free and open to all healthcare professionals including nurses, providers, pharmacists, administrators, and any facility staff involved in patient care. More information can be found on this flier, feel free to print and display the flier at your facility for your staff. The first session is on March 25, 2025, from 12pm-1pm CST, click here to register.
We hope you will join us for this important learning opportunity. If you have any questions, please contact Loretta Bryan.
These 3 sessions have been submitted for approval for 1.0 CME each via AAAP/ORN through ACCME and will meet the requirements for DEA licensure.
